13.18500 EUR
0.235
1.75%
Last update Dec 16, 8:13 AM CET
Main market
Day range
13.18500
13.18500
Previous close
13.42000
Open
13.18500
Access this stock data via API
Subscribe
Aurinia Pharmaceuticals Inc.
13.19
0.24
1.75%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 62.6M 59.7M 53.2M 51.0M
Cost of revenue 7.0M 6.1M 7.3M 4.7M
Gross profit 55.6M 53.6M 45.9M 46.3M
Operating expense
Research & development 7.2M 6.3M 4.9M 6.9M
Selling general and admin 22.3M 22.2M 17.3M 38.6M
Other operating expenses 791.7K 7.9M 3.8M -3.8M
Operating income 25.4M 17.2M 19.9M 11.7M
Non operating interest income
Income 2.8M 2.7M 3.0M 3.4M
Expense 936.6K 952.0K 909.4K 976.7K
Other income expense -97.2K -1.3M -13.1M
Pretax income 27.2M 18.9M 20.8M 999.7K
Tax provision 350.3K 548.0K 856.5K -218.2K
Net income 26.9M 18.3M 19.9M 1.2M
Basic EPS 0.2 0.2 0.0
Diluted EPS 0.2 0.2 0.0
Basic average shares 114.9M 118.4M 121.2M
Diluted average shares 117.2M 118.4M 125.9M
EBITDA 32.3M 24.1M 27.1M 19.2M
Net income from continuing op. 26.9M 18.3M 19.9M 1.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 37 minutes

09:22
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).